Prevention of steroid-induced intraocular pressure elevation.
Kahana
Alon
A
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D003598:Cytoskeletal Proteins / Q000378:metabolism; D004008:Diclofenac / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D005136:Eye Proteins / Q000378:metabolism; D005902:Glaucoma, Open-Angle / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D005938:Glucocorticoids / Q000009:adverse effects*; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D011239:Prednisolone / Q000009:adverse effects*; D014129:Trabecular Meshwork / Q000378:metabolism; D000099179:Myocilin
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003598:Cytoskeletal Proteins; D004008:Diclofenac; D005136:Eye Proteins; D005938:Glucocorticoids; D006023:Glycoproteins; D011239:Prednisolone; D000099179:Myocilin